Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.

Translated title of the contribution: Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.
Original language	Undefined/Unknown
Pages (from-to)	100-108
Number of pages	9
Journal	Leukemia Research
Volume	33
Issue number	1
Publication status	Published - 2009

AB Leukema Research Jan2009
Final published version, 815 KB
Embargo ends: 01/01/2050 00:00 CET

Cite this

@article{697cfe1f3c354fcf96348cfa1f210d0b,

title = "Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.",

author = "\{van der Spek\}, E. and A.C. Bloem and H.M. Lokhorst and \{van Kessel\}, B. and \{Bogers - Boer\}, L.H. and \{van de Donk\}, N.W.C.J.",

year = "2009",

language = "Undefined/Unknown",

volume = "33",

pages = "100--108",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "1",

}